Jack Bergman Selected Research

AM4113

1/2016	Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
2/2013	Analysis of tolerance and behavioral/physical dependence during chronic CB1 agonist treatment: effects of CB1 agonists, antagonists, and noncannabinoid drugs.
3/2008	Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack Bergman Research Topics

Disease

7	Cocaine-Related Disorders (Cocaine Addiction) 10/2018 - 04/2002
6	Opioid-Related Disorders (Opiate Addiction) 08/2022 - 12/2008
6	Vomiting 01/2021 - 03/2008
4	Substance-Related Disorders (Drug Abuse) 01/2019 - 10/2012
3	Tremor (Tremors) 01/2022 - 01/2016
2	Schizophrenia (Dementia Praecox) 02/2022 - 01/2019
2	Anhedonia 01/2021 - 03/2013
2	Mood Disorders (Mood Disorder) 01/2021 - 01/2020
2	Pain (Aches) 12/2019 - 12/2017
2	Tobacco Use Disorder (Nicotine Dependence) 12/2017 - 08/2015
2	Nausea 03/2013 - 03/2008
1	Alzheimer Disease (Alzheimer's Disease) 02/2022
1	Central Nervous System Diseases (CNS Diseases) 02/2022
1	Sleep Deprivation 01/2022
1	Major Depressive Disorder (Major Depressive Disorders) 01/2021
1	Sialorrhea 01/2020
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2020
1	Feeding and Eating Disorders (Eating Disorder) 01/2019
1	Marijuana Abuse (Cannabis Abuse) 01/2016
1	Shock 02/2013
1	Hypothermia 01/2013
1	Chronic Disease (Chronic Diseases) 02/2011
1	Catalepsy 12/2008
1	Obesity 03/2008
1	Hypertension (High Blood Pressure) 10/2006
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 04/2005

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 02/2022 - 11/2013
5	Opioid Analgesics (Opioids)IBA 08/2022 - 02/2013
5	Nicotine FDA Link 01/2020 - 08/2015
5	Cocaine (Cocaine HCl)IBA 01/2019 - 04/2002
4	RimonabantIBA 01/2016 - 03/2008
3	3- (1- hexylcyclobut- 1- yl)- 6a,7,8,9,10,10a- hexahydro- 6,6- dimethyl- 6H- dibenzo(b,d)pyran- 1,9 diolIBA 01/2022 - 01/2013
3	CannabinoidsIBA 01/2022 - 01/2013
3	Dronabinol (THC)FDA LinkGeneric 01/2021 - 11/2013
3	AM4113IBA 01/2016 - 03/2008
3	Dopamine (Intropin)FDA LinkGeneric 02/2013 - 03/2007
2	Antidepressive Agents (Antidepressants)IBA 01/2021 - 01/2021
2	Buprenorphine (Subutex)FDA LinkGeneric 11/2019 - 02/2011
2	Serotonin (5 Hydroxytryptamine)IBA 12/2018 - 12/2017
2	lorcaserinIBA 12/2018 - 12/2017
2	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 11/2013 - 01/2013
2	Naltrexone (ReVia)FDA LinkGeneric 02/2013 - 02/2011
2	Mesylates (Mesylate)IBA 02/2013 - 01/2013
2	Methamphetamine (Desoxyn)FDA LinkGeneric 02/2013 - 10/2012
2	9- (hydroxymethyl)- 3- (1- adamantyl)hexahydrocannabinolIBA 02/2013 - 01/2013
1	Fentanyl (Sublimaze)FDA LinkGeneric 08/2022
1	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 02/2022
1	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2022
1	Scopolamine (Hyoscine)FDA Link 01/2021
1	Therapeutic UsesIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Muscarinic AntagonistsIBA 01/2021
1	Lithium ChlorideIBA 01/2020
1	AntiemeticsIBA 01/2020
1	Analgesics (Analgesic Drugs)IBA 11/2019
1	Opioid Receptors (Opioid Receptor)IBA 11/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	aldehyde dehydrogenase (NAD(P)+) (acetaldehyde dehydrogenase)IBA 10/2018
1	Disulfiram (Antabuse)FDA Link 10/2018
1	Dopamine beta-HydroxylaseIBA 10/2018
1	EndocannabinoidsIBA 12/2017
1	5-HT2C Serotonin ReceptorIBA 12/2017
1	epibatidineIBA 01/2016
1	CotinineIBA 01/2016
1	AlkaloidsIBA 01/2016
1	VaccinesIBA 08/2015
1	Nicotinic AgonistsIBA 03/2014
1	Ro 61-8048IBA 11/2013
1	Buspirone (Buspar)FDA LinkGeneric 03/2013
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 03/2013
1	Dopamine Receptors (Dopamine Receptor)IBA 03/2013
1	Morphine (MS Contin)FDA LinkGeneric 02/2013
1	Haloperidol (Haldol)FDA LinkGeneric 02/2013
1	SCH 23390IBA 02/2013
1	methanandamideIBA 02/2013
1	quinolineIBA 02/2013
1	pyrazoleIBA 02/2013
1	Dopamine D3 ReceptorsIBA 10/2012
1	Heroin (Diamorphine)IBA 02/2011
1	Aripiprazole (Abilify)FDA Link 12/2008
1	enadolineIBA 12/2007
1	kappa Opioid Receptors (kappa Opioid Receptor)IBA 12/2007
1	EthylketocyclazocineIBA 12/2007
1	Methylphenidate (Ritalin)FDA LinkGeneric 04/2005
1	Dopamine D1 Receptors (Dopamine D1 Receptor)IBA 04/2002

Therapy/Procedure

5	Drug Therapy (Chemotherapy) 01/2020 - 12/2007
4	Self Administration (Administration, Self) 12/2018 - 04/2002
1	Therapeutics 01/2021
1	Immunotherapy 08/2015
1	Analgesia 01/2013
1	Operative Surgical Procedures 10/2006